No increased susceptibility to breast cancer from combined CHEK2 1100delC genotype and the HLA class III region risk factors.
de Jong MM, Nolte IM, Te Meerman GJ, van der Graaf WT, Oosterom E, Bruinenberg M, Steege Gv, Oosterwijk JC, van der Hout AH, Boezen HM, Schaapveld M, Kleibeuker JH, de Vries EG.
de Jong MM, et al. Among authors: boezen hm.
Eur J Cancer. 2005 Aug;41(12):1819-23. doi: 10.1016/j.ejca.2005.04.035.
Eur J Cancer. 2005.
PMID: 16043347